Edwards Lifesciences: Bullischer Impuls am EMA20!
Wo liegen die nächsten Kursziele? Rückblick Edwards Lifesciences ist ein führendes Unternehmen für Innovationen im Bereich der strukturellen Herzerkrankungen. In ...
Sunday, January 11, 2026
Tag: Edwards
Edwards buys 48% stake in Vectorious Medical at $497m valuation
Israeli company Victorious Medical Technologies, which develops therapies for structural heart disease, has announced that it has been acquired ...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.